Key result
The TT genotype at position +874 of the IFN-γ gene was significantly associated with increased susceptibility to dilated cardiomyopathy (OR 1.55; 95% CI 1.12-2.15; p=0.009).
Why the study?
Are polymorphisms in the IFN-γ and MHC2TA genes associated with susceptibility and prognosis in patients with idiopathic dilated cardiomyopathy?
Case-Control (n=867)
Are polymorphisms in the IFN-γ and MHC2TA genes associated with susceptibility and prognosis in patients with idiopathic dilated cardiomyopathy?
The TT genotype of the IFN-γ gene is associated with a 50% higher risk of developing dilated cardiomyopathy, emphasizing the role of immune factors in DCM pathology.
Does not support IFN-γ genotyping in DCM care; leaves open need for prospective validation of genetic susceptibility.
The etiology of idiopathic dilated cardiomyopathy (DCM) is largely unknown. One hypothesis is that immunological factors are responsible for disease development. Single nucleotide polymorphisms (SNP) at position +874 of the IFN-γ gene and at position -168 of the MHC2TA gene have previously been shown to associate with infl ammatory and autoimmune disorders. We analysed their possible infl uence on susceptibility and prognosis in patients with DCM. Genotypes were determined by real-time PCR in 442 patients and 425 controls. Genotype frequencies were found signifi cantly different between patients and controls for IFN-γ (p=0.029), but not for MHC2TA (p=0.26). In a logistic regression analysis, the high producing TT genotype of IFN-γ was signfi cantly more common in patients than controls (OR 1.55 [1.12-2.15], p=0.009). None of the polymorphisms had an infl uence on long-term outcome, 10-years mortality with a HR of 0.94 (p=0.74) and 0.85 (p=0.30), IFN-γ and MHC2TA, respectively. A 50% higher risk to develop DCM for individuals with the TT genotype of the IFN- gene is a new finding and emphasize the role of IFN- in DCM pathology.
No takes yet. Share an insight, caveat, or question.
A 2010 study conducted a case-control in Idiopathic dilated cardiomyopathy (DCM) (n=867). TT genotype of the IFN-γ gene at position +874 vs. Controls was evaluated on Susceptibility to dilated cardiomyopathy (OR 1.55, 95% CI 1.12-2.15, p=0.009). The TT genotype at position +874 of the IFN-γ gene was significantly associated with increased susceptibility to dilated cardiomyopathy (OR 1.55; 95% CI 1.12-2.15; p=0.009).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: